Lithotech Medical acquired by U.S. based Vention Medical

Vention Medical has finalized its acquisition of Israeli-based Lithotech Medical. Lithotech has developed complex nitinol (nickel titanium) wire-based technologies for use in the design and manufacture of medical devices. The acquisition is for NIS 10 million in cash and a further NIS 3 million in milestone performance payments as reported by Capital Point Ltd. (TASE:CPTP), which owns a 13.6% stake in Lithotech.

To read the full release, click here.

Author: Ethan Goldspiel

Comments are disabled.